09:49 AM EST, 11/22/2024 (MT Newswires) -- Aptose Biosciences ( APTO ) said Friday that it plans to sell 40 million shares and 20 million warrants worth $8 million in a public offering.

The offering is expected to be completed on Monday, the company said.

Net proceeds will be used for working capital and general corporate purposes, the company said.

Aptose Biosciences' ( APTO ) shares were down nearly 45% in recent trading.

Price: 0.13, Change: -0.11, Percent Change: -45.90